James L. Leenstra

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas

Matthew H. G. Katz, Qian Shi, Jeff Meyers et al. · JAMA Oncology · 2022 · 260 citations · Full text

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Matthew H. G. Katz, Fang‐Shu Ou, Joseph M. Herman et al. · BMC Cancer · 2017 · 188 citations · Full text

Central neurocytoma: Management recommendations based on a 35-year experience

James L. Leenstra, Fausto J. Rodríguez, Christina M. Frechette et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 166 citations

Neuro-oncology, Neuroanatomy, Clinical Neurology +7

Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.

Matthew H. G. Katz, Qian Shi, Jeffrey P. Meyers et al. · Journal of Clinical Oncology · 2021 · 142 citations

Surgical Oncology, Br Pdac, Neoadjuvant Therapy +19

Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])

James L. Leenstra, Robert C. Miller, Rui Qin et al. · Journal of Clinical Oncology · 2014 · 88 citations · Full text